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470a Tuesday, March 3, 2009IGF-1 effect, supporting the involvement of a serine-threonine phosphatase in
IGF-1 activity (De Luca et al., Br. J. Pharmacol. 1998). Angiotensin receptor
antagonists and other tools are in use to gain further insight in the mechanisms
involved in inflammation-sensitive ClC-1 impairment in muscular dystrophy
(Telethon-Italy GGP05130).
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Resting chloride conductance (gCl) sustained by the ClC-1 chloride channel
have a crucial role in muscle physiology by maintaining the sarcolemma elec-
trical stability. Its reduction can produce myotonia-like symptoms. ClC-1 chan-
nel has been shown to be a target of therapeutic molecules such as statins and
fibrates. We previously demonstrated that lipophilic statins and fibrates affect
skeletal muscle function by reducing resting chloride conductance (gCl)
(Pierno et al, Br J Pharmacol 149:909, 2006). Here we studied the time course
changes of fluvastatin (20 mg/kg) and fenofibrate (60 mg/kg) effects on Exten-
sor Digitorum Longus (EDL) muscle gCl measured by two-microelectrode
current clamp method. The gCl decreased in a time-dependent manner, being
significantly lower after 1 week (2464566 mS/cm2, n¼46 and 2510553 mS/cm2,
n¼50 in fluvastatin and fenofibrate treated rats, with respect to 2706583
mS/cm2, n¼27 of control). To investigate the causes of gCl reduction we ana-
lyzed the ClC-1 gene expression by real-time quantitative PCR. The results
showed a marked decrease in ClC-1 mRNA expression in both fluvastatin and
fenofibrate chronically treated animals which contributes to gCl reduction. To
study the involvement of other proteins essential for muscle function we ana-
lysed the proteomic map of EDL muscle from rat treated with fluvastatin
(20mg/kg), atorvastatin (10mg/kg), fenofibrate (60mg/kg) and with combined
fluvastatin (5mg/kg) plus fenofibrate (30mg/kg) by two-dimensional gel electro-
phoresis (Gelfi et al, J Proteome Res 5:1344, 2006). Fluorescent stained proteo-
mic map showing ~500 spots were obtained and 40, 74, 60 and 76 differently
expressed proteins were found in the above mentioned treated groups, with re-
spect to control. The identification of each spot will allow to identify the protein
targets of the myopathic process.
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The Cl pathway of E. Coli ClC Hþ/Cl exchanger has three binding sites that
can be occupied by Cl, however SeCN (an anion similar to SCN) occupies
only one site. This pathway serves as a model for pore structure of ClC channels
whose gating is coupled to permeation. Thus ClC channels may gate differently
in the presence of SCN. We analyzed the relationship between gating and pore
properties by performing SCN mole-fraction experiments in ClC-2 channels
expressed in HEK cells. Internal and external solutions with different SCN
fractions were prepared mixing [Cl] þ [SCN] ¼ 140 mM. Replacing
100%Clwith SCN on both sides of the membrane shifted to the left the volt-
age (Vm) vs channel P0 curve by ~-18 mV without changing the slope. In con-
trast, the protopore gate PP vs Vm curve was shallower and shifted rightward
(þ5 mV). Extracellular SCN mole-fractions produced negative shifts on re-
versal potential (ER) values which are not described by GHK equation with
a constant PSCN/PCl ratio. The PSCN/PCl ratios increased from 1.4 to 2.5 when
the mole fraction increased, suggesting extracellular SCN enters the pore
better than Cl. In addition, the slope of P0 vs Vm curve was steeper and the
mid-point voltage (V0.5) did not change. Intracellular SCN
 mole fractions
produced nonlinear negative shifts on ER suggesting that from this side Cl
 en-
ters the pore better than SCN. The slope of the Po vs Vm curve was shallower
and V0.5 and slope conductance vs mole fraction displayed the classical anom-
alous behaviour. Interestingly, the protopore gate located in the Cl pathway
also displays the same behaviour. Our data show that the ClC-2 channel has
indeed a multi-ion pore and that SCN enters this pore preferably from the
extracellular side.
Supported by CONACyT.
2425-Pos Board B395
Pharmacological Characterization of GaTx2, a Peptide Inhibitor of ClC-2
Chloride Channels
Christopher H. Thompson1, Cody S. Freeman1, Robert J. French2,
Nael A. McCarty3.1Georgia Institute of Technololgy, Atlanta, GA, USA, 2University of
Calgary, Calgary, AB, Canada, 3Emory University School of Medicine,
Atlanta, GA, USA.
ClC-2 chloride channels are voltage-gated ion channels that are expressed in
neuronal and epithelial cells where they are critical mediators for the passive
diffusion of Cl across the plasma membrane. Although ClC-2 is nearly ubiq-
uitously expressed in mammalian cells, many details regarding channel bio-
physics and the physiological role that ClC-2 channels play remain undefined.
We recently isolated the first peptide toxin active against ClC channels: Geor-
gia anion toxin 2 (GaTx2), a 3.2 kDa peptide composed of 29 residues with
three disulfide bonds. Here, we describe the basic pharmacological features
of the inhibitory activity of GaTx2 against ClC-2, including affinity, mecha-
nism of inhibition, and specificity. Using two-electrode voltage-clamp, we cre-
ated a dose-response curve for inhibition of ClC-2 by GaTx2 at VM¼ -100 mV,
and calculated a KD of 225 10 pM. This value was very similar to the value
obtained from dose-response curves created from multi-channel patches, which
gave a KD of 125 5 pM. Additionally, from TEVC recordings we measured
kon ¼ 43 x 106 M1s1, and koff ¼ 0.0034 s1, which is consistent with rate
constants for other peptide inhibitors. Single channel recording showed that
the latency to first opening is increased nearly 8 fold in the presence of
20 pM GaTx2. Also, outside-out macropatches revealed that GaTx2 is unable
to inhibit open ClC-2 channels; thus, this toxin may act as a gating modifier.
Finally, we found that GaTx2 is specific for ClC-2, being unable to inhibit other
ClC channels or transporters, other major classes of Cl channels, or voltage-
dependent Kþ channels. This high affinity, highly specific inhibitor of ClC-2
will provide an excellent tool for studies designed to understand the function
and regulation of this channel, and will help define its physiological role(s).
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All-atom NMA is used to explore possible mechanisms for slow gating in ClC
Cl channels. As the ‘‘double-barreled’’ architecture is well established
throughout the ClC family, both channels and transporters (Miller, 2006.
Nature. 440:484), we use the high-resolution (2.5 A˚) X-ray structure of an
E. coli ClC transporter (pdb entry 1OTS) as a template, describe it with the
CHARMM22 force field and carry out standard all-mode NMA. The slowest,
intrinsic motions encoded in the structure are determined by protein shape. Per-
turbing the system in either direction along the 7th all-atom NM leads to slow
relative swinging of the subunits, perpendicular to the membrane plane. The in-
plane swivel axis lies at the subunit interface, near the protein’s center. The in-
tracellular interfacial domain is the region most affected. Here the two halves of
the protein oscillate, separating and then nearly touching. The R and A helices
execute large scale swaying, alternately increasing and decreasing their cyto-
plasmic ends’ separations, motion in agreement with FRET experiments (By-
kova et al., 2006. Nat. Struct. Biol. 13:1115). The ion-occupied intracellular
pores behave as almost rigid units. As the subunits separate, the intracellular
pore tilt relative to the membrane plane changes notably. In contrast, the extra-
cellular portion of the subunit interface is significantly less affected, although
small interfacial structural changes are clearly observable. Those extracellular
regions structurally affected by the subunits’ slow sway are localized near the
extracellular Cl pathways. As the subunits separate, these regions compress,
possibly shutting the extracellular pores. As they approach, the extracellular
regions near the Cl conduction pathways relax, possibly opening them.
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ClC Hþ/Cl exchangers are homodimers with three Cl-binding sites within
each monomer. Previous studies suggest that transport cycles are triggered by
protonation of the lateral chain of a glutamate residue (E148) located in the
middle of the Cl pathway. In this work, we performed ab initio density func-
tional theory calculations using the ultra soft pseudopotential approach in
order to gain insight about microscopic movements induced by H and/or Cl
during transport activity. For these computations the 16 amino-acids that
line the Cl pathway were spatially aligned according to the X-ray structure.
We found that the orientation of the unprotonated E148 carboxy group was
influenced when Cl was in close proximity. Attaching a single H to this
COO group displaced the lateral chain (with respect to the unprotonated
structure) towards the extracellular side and led to the formation of a sizable
hole in the entryway. When Cl was placed at 2A˚ from the protonated COO
group (COOH) (in both intra- and extra-cellular positions) the conformational
